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ABSTRACT
All arthropod-borne flaviviruses generate a short noncoding RNA (sfRNA) from the viral 39 untranslated region during infection
due to stalling of the cellular 59-to-39 exonuclease XRN1. We show here that formation of sfRNA also inhibits XRN1 activity.
Cells infected with Dengue or Kunjin viruses accumulate uncapped mRNAs, decay intermediates normally targeted by XRN1.
XRN1 repression also resulted in the increased overall stability of cellular mRNAs in flavivirus-infected cells. Importantly,
a mutant Kunjin virus that cannot form sfRNA but replicates to normal levels failed to affect host mRNA stability or XRN1
activity. Expression of sfRNA in the absence of viral infection demonstrated that sfRNA formation was directly responsible for
the stabilization of cellular mRNAs. Finally, numerous cellular mRNAs were differentially expressed in an sfRNA-dependent
fashion in a Kunjin virus infection. We conclude that flaviviruses incapacitate XRN1 during infection and dysregulate host
mRNA stability as a result of sfRNA formation.
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INTRODUCTION
The cellular mRNA decay machinery plays an important
role in determining both the quantity and quality of gene
expression (Garneau et al. 2007). The steady-state level of
a given transcript is largely determined through coordina-
tion of transcription and mRNA decay (Elkon et al. 2010;
Shalem et al. 2011). In fact, recent data suggest that the
processes of transcription and cytoplasmic mRNA decay
may be much more tightly coordinated than previously
suspected (Bregman et al. 2011; Trcek et al. 2011). Based on
global analyses performed in response to various stimuli,
z17%–50% of changes in mRNA levels are primarily a
result of altered mRNA stability (Cheadle et al. 2005;
Schwanha¨usser et al. 2011). In addition, the cellular mRNA
decay machinery rapidly and efficiently removes unwanted
transcripts such as mRNAs with premature termination
codons and damaged or malformed RNAs (Mu¨hlemann
and Jensen 2012). Hence, the mRNA decay machinery is
clearly a major force in cellular RNA metabolism, and dis-
rupting it can lead to a variety of biological effects (Schaljo
et al. 2009; Astuti et al. 2012).
Pathways of mRNA decay are often initiated by short-
ening of the poly(A) tail, a process referred to as de-
adenylation (Chen and Shyu 2011). Decay can also be initiated
through alternative mechanisms, including endonucleo-
lytic cleavage by targeted nucleases via small regulatory
miRNAs or siRNAs or other factors (Schoenberg 2011).
Deadenylation-initiated decay is thought to be the primary
pathway for the demise of most cellular mRNAs. These
initiating events in mRNA decay feed the transcript into
one of two exonucleolytic pathways. The 59-to-39 exonu-
cleolytic pathway begins with a coordinated set of proteins
recruiting a decapping enzyme (DCP2 or NUDT16) to re-
move the 59 methylated cap structure (Li et al. 2011). This
generates a transcript bearing a 59 monophosphate that is
rapidly and processively degraded by the 59-to-39 exoribo-
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nuclease XRN1 (Chang et al. 2011; Jinek et al. 2011). Alter-
natively, proteins associated with the exosome complex
attack the transcript exonucleolytically from the 39-to-59
direction (Lykke-Andersen et al. 2011; Astuti et al. 2012).
XRN1-mediated decay is considered in many current models
to be the major pathway of mRNA decay in cells (Stoecklin
et al. 2006), although it is clear that exosome-mediated
39-to-59 decay may also make a significant contribution
(Murray and Schoenberg 2007). Factors associated with the
59-to-39 decay pathway can often be colocalized in cytoplas-
mic granules referred to as Processing or P-bodies, suggest-
ing a coordination and/or coregulation of factors and steps
in this pathway (Kulkarni et al. 2010).
Growing evidence indicates that when RNA viruses in-
fect cells their transcripts use several strategies to interface
successfully with and/or avoid the cellular RNA decay ma-
chinery. Some RNA viruses that encode polyadenylated
transcripts appear to usurp cellular RNA-binding proteins
to stabilize their transcripts (Sokoloski et al. 2010; Palusa
et al. 2012). Poliovirus, interestingly, appears to cause the
accelerated turnover of several proteins involved in the 59–
39 RNA decay pathway, including XRN1 and the auxiliary
decapping factor DCP1a (Dougherty et al. 2011). Poliovirus
also causes the apparent degradation or inhibition of fac-
tors that initiate decay as well, including the deadenylase
component PAN3 (Dougherty et al. 2011) and the endo-
ribonuclease RNase L (Townsend et al. 2008). Disruption
of the cellular RNA decay machinery can have a variety of
benefits for the virus, including increased stability of viral
transcripts as well as interference with the regulation of
cellular gene expression that may influence the ability of
the cell to mount an effective innate immune response
(Dickson and Wilusz 2011).
During infection, all arthropod-borne flaviviruses tested
to date generate a small RNA termed subgenomic flavivi-
rus RNA (sfRNA) from their 39 untranslated region (UTR)
(Pijlman et al. 2008). Interestingly, sfRNA was shown not to
be the result of transcription from an internal promoter.
RNAi-mediated knockdowns and applications of a recom-
binant yeast enzyme suggest that sfRNA is generated as
a viral genomic RNA decay product by the action of the
XRN1 exoribonuclease (Pijlman et al. 2008). XRN1 appears
to stall at a set of conserved pseudoknot-like structures at
the 59 side of the flavivirus 39 UTR (Funk et al. 2010; Silva
et al. 2010). Importantly, the ability of West Nile virus to
generate sfRNA has been linked to cytopathology in in-
fected cells and pathogenicity in mice (Pijlman et al. 2008;
Funk et al. 2010; Schuessler et al. 2012). Thus, understanding
the consequences of sfRNA generation in flavivirus-infected
cells may provide significant insights into an underexplored
area of virus–host interactions.
In this study, we have determined that stalling of the
XRN1 enzyme in the process of generating sfRNA results
in the repression of its activity. The repression of XRN1 by
sfRNA formation is a direct result of the XRN1 protein–RNA
interaction and does not require any auxiliary factors.
Inhibition of XRN1 activity in flavivirus infections was
demonstrated by the increased accumulation of uncapped
mRNA decay intermediates and prolonged cellular mRNA
half-lives in Dengue and West Nile virus (Kunjin strain)
infections. Interestingly, the extension of mRNA half-lives
can be directly attributed to sfRNA formation because it is
not seen in cells infected with a mutant virus that cannot
make sfRNA. However, cellular mRNA stabilization can be
reproduced by generating sfRNA in the absence of viral
infection. The inactivation of XRN1 and the associated
increase in the stability of cellular transcripts coincide with
an sfRNA-dependent overexpression of a variety of cellu-
lar mRNAs. Collectively, these data suggest a novel role
for this small noncoding sfRNA in the dysregulation of
cellular mRNA expression.
RESULTS
Formation of sfRNA by the cellular XRN1
exoribonuclease represses enzymatic activity
Previous work using sh/siRNA-mediated Xrn1 knockdown
in infected cells or incubation with a recombinant Xrn1
protein derived from yeast have strongly implicated a role
for the cellular exoribonuclease in the formation of sfRNA
from West Nile virus and Yellow Fever virus 39 UTRs
(Pijlman et al. 2008; Silva et al. 2010). To extend these
observations, we inserted the 39 UTR of Dengue virus type 2
(DenV2) into a reporter construct and prepared in vitro–
transcribed RNAs bearing a 59 monophosphate so that
they would be effective substrates for XRN1. As seen in
Figure 1A, while the reporter RNA lacking DenV2 se-
quences was effectively degraded by recombinant yeast
XRN1 with no apparent decay intermediates, the reporter
containing the 39 UTR efficiently generated an sfRNA-like
decay product due to stalling of XRN1 at the 59 end of the
DenV2 39 UTR. To demonstrate that XRN1-like activity
from human or mosquito cells can also generate sfRNA, the
same constructs were incubated in HeLa (Fig. 1B) or C6/36
mosquito cell (Fig. 1C) cytoplasmic extracts under condi-
tions that favor almost exclusively 59-to-39 exonucleolytic
decay of RNA substrates (Mukherjee et al. 2002). Both
extracts efficiently degraded the control RNA containing a
59 monophosphate but generated an sfRNA-like decay
intermediate from RNAs containing the DenV2 39 UTR.
Thus we conclude that XRN1 from multiple organisms
stalls at the proximal side of the DenV2 39 UTR to generate
an sfRNA. This is surprising given that XRN1 is a pro-
cessive and highly efficient exoribonuclease on the vast
majority of RNA substrates.
The stalling of XRN1 on RNA substrates as abundant
as those generated during a viral infection could have sig-
nificant impact on its ability to function effectively as an
enzyme. If XRN1 was only slowly released (or not released
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at all) from RNA substrates that it stalls on, its ability to
function as a 59-to-39 exonuclease would be inhibited. To
test this possibility, we incubated XRN1 from a variety of
sources with a reporter RNA in the presence of a 30-fold
excess of a competitor RNA. The RNA competitors used
in this experiment were either a transcript that contained
the 39 UTR of DenV2 capable of stalling XRN1 and form-
ing an sfRNA-like decay intermediate or a nonspecific
transcript of similar length. We also used two forms of
the competitor RNAs: 59-capped transcripts that would be
naturally resistant to 59-exonuclease digestion and tran-
scripts containing a 59 monophosphate that would be
rapidly attacked by XRN1. In this way, we could determine
whether there was a requirement for the competitor to be a
substrate for XRN1 digestion in order to influence enzy-
matic activity or if the sequence of the RNA competitor
alone was sufficient to see any effects observed. As seen in
Figure 2A, the addition of nonspecific competitor RNA had
no effect on XRN1-mediated decay of a radiolabeled re-
porter in HeLa extracts. This was true regardless of whether
the 59 end was capped or bore a monophosphate and con-
firmed that the XRN1 enzyme was in excess under the con-
ditions used in the experiment. Interestingly, a competitor
RNA containing the DenV2 39 UTR repressed XRN1 ac-
tivity, but only when the competitor transcript contained
a 59 monophosphate and could recruit XRN1 to the 59 end
to form sfRNA. These data indicate that RNAs containing
the DenV2 39 UTR can repress XRN1 activity, but only when
they can also serve as substrates for the enzyme. The
presence of the DenV2 39-UTR sequence on a transcript
with a 59 end blocked by a 7-methyl G cap structure did
not efficiently repress XRN1 activity. The DenV2 39-UTR
competitor RNA bearing a 59 monophosphate also effec-
tively repressed XRN1 activity in C6/36 mosquito extracts
(Fig. 2B) and, notably, repressed purified recombinant
XRN1 protein (Fig. 2C). These data indicate that the
repression of XRN1 activity by sfRNA generation does
not require auxiliary cellular factors, although cellular fac-
tors may modulate the efficiency of the repression. In
summary, we conclude that XRN1 exoribonuclease from
divergent eukaryotic organisms (yeast, human, and mos-
quito) can be inhibited as a result of stalling during for-
mation of sfRNA.
Formation of sfRNA impairs XRN1 activity
in flavivirus-infected cells
Since sfRNA formation effectively blocked XRN1 activity
in cell-free assays, the next important question to address
was whether XRN1 activity is also repressed in flavivirus-
infected cells. A major pathway of cellular mRNA decay
involves decapping and subsequent rapid degradation of
the resulting transcripts that contain a 59 monophosphate
by the XRN1 exonuclease (Garneau et al. 2007). Therefore,
an increased abundance of uncapped mRNA decay inter-
mediates would be a strong indication of XRN1 inhibition
in flavivirus-infected cells. Human 293T cells were infected
with DenV2, and total RNA was obtained at 4 d post-
infection when levels of sfRNA in cells were high. Total
RNA samples were immunoprecipitated with an excess
amount of an antibody specific to the methylated cap
structure, and the supernatant fraction was analyzed for
uncapped FOS or TUT1mRNAs by qRT-PCR. These mRNAs
were chosen to represent transcripts that were relatively
short-lived (FOS) or have an average half-life (TUT1). The
7SL RNA, which naturally lacks a 59 cap, was used as a
reference. In addition, values were normalized to the rela-
tive amount of each mRNA present in the cap-containing
precipitated fraction. As seen in Figure 3A, the amount
of uncapped FOS or TUT1 mRNAs was reproducibly
almost twofold higher in DenV2-infected cells as compared
with mock-infected controls. The relative amount of un-
capped RNAs was z4% in mock-infected cells and z8%
of the total mRNA in DenV2-infected cells. To generalize
this observation to other arthropod-borne flaviviruses that
generate an sfRNA, the experiment was repeated with the
Kunjin subtype of West Nile virus recovered from the
infectious cDNA clone FLSDX (Khromykh et al. 1998). As
seen in Figure 3B, the amounts of uncapped FOS or TUT1
mRNAs were substantially higher in Kunjin virus–infected
cells. The relative amount of uncapped RNAs was z4%
in mock-infected cells and z6%–8% of the total mRNA
in Kunjin virus–infected cells. Finally, we performed the
FIGURE 1. XRN1 stalls at the 59 border of the Dengue virus 39 UTR
to generate sfRNAs. Radiolabeled reporter RNAs derived from a
pGem4 template (Reporter Only) or RNAs from the same plasmid
containing the stem–loop 1 region of the 39 UTR of Dengue virus
type 2 (Reporter + DenV 39 UTR) were generated with a 59 mono-
phosphate as substrates for the XRN1 exonuclease. The RNAs were
incubated with recombinant yeast XRN1 (A), or cytoplasmic extracts
from HeLa (B) or Aedes C6/36 (C) cells under conditions in which
XRN1-mediated 59–39 decay predominates. Reaction products were
analyzed on 5% polyacrylamide gels containing urea and visualized by
phosphorimaging. The position of sfRNA-like reaction products is
indicated on the right.
sfRNA inhibits the cellular exonuclease XRN1
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experiment using a mutant Kunjin virus (FL-IRAdCS3)
that replicated to similar levels as wild-type Kunjin virus
in 293T cells as measured by qRT-PCR (Supplemental
Fig. 1A) but failed to produce sfRNA (see Fig. 7; Pijlman
et al. 2008). Importantly, the sfRNA-deficient Kunjin virus
strain failed to cause the accumulation of uncapped FOS
or TUT1 mRNAs in infected cells (Fig. 3B). Similar differ-
ences were evident when uncapped RNA levels were nor-
malized to total mRNA levels (data not shown). These data
strongly suggest that XRN1 activity is specifically repressed
by the generation of sfRNA during flavivirus infections.
XRN1 is preferentially associated with the flavivirus
39 UTR/sfRNA during infection
Given the results in Figure 2C showing that purified re-
combinant XRN1 can be inhibited by sfRNA formation,
the most likely mechanism for the repression of XRN1
activity by sfRNA formation is that the enzyme remains
bound to the RNA. To demonstrate this in flavivirus-
infected cells, RNA–protein complexes in human 293T cells
infected with Kunjin virus or Dengue virus were cross-linked
with formaldehyde at 2 or 4 d post-infection (respectively),
and XRN1 antibodies were used to immunoprecipitate
XRN1 and any associated RNAs from cell lysates. Pre-
cipitated RNAs were isolated and RT-PCR was performed
using primers to a region of the NS3 portion of the Kunjin
virus open reading frame (ORF) or the NS5 ORF of
DenV2 just upstream of the 39 UTR or
using primers to the viral 39 UTR that
would be present in sfRNA species. As
seen in Figure 4A, XRN1 antibodies
preferentially precipitated viral RNAs
that contained the 39-UTR sequences
as compared with the upstream NS3 or
NS5 sequences. To confirm these data,
quantitative RT-PCR was performed us-
ing the same primers on independently
immunoprecipitated samples. As seen in
Figure 4B, the 39 UTR was significantly
enriched over the NS3 or NS5 regions,
respectively, of the Kunjin or Dengue
viral ORFs in the XRN1 coprecipitated
fractions. The twofold higher relative
levels of 39-UTR-containing RNAs as-
sociated with XRN1 in the DenV2 in-
fections is likely a factor of the longer
time point (4 d post-infection) com-
pared with the 2-d post-infection point
used for the Kunjin virus–infected sam-
ples. The small overall increase in the
amount of viral 39 UTR relative to full-
length genomic RNA due to the gen-
eration of sfRNA is not sufficient to
account for the enrichment observed in
the immunoprecipitated fractions. In addition, the effi-
ciencies of the primers used in each set of qPCR reactions
were within 2% of each other, indicating that the differ-
ences observed were not due to primer sensitivities. There-
fore, we conclude that XRN1 was preferentially associated
with viral transcripts that contained the 39 UTR but lacked
the upstream ORF (i.e., sfRNA).
The formation of sfRNA and depletion of XRN1
activity are associated with the stabilization
of cellular mRNAs
Since XRN1 is a key component in the major 59-to-39
pathway of mRNA decay in cells, we hypothesized that
repression of its function could result in a significant stabi-
lization of cellular mRNAs. While the accumulation of
uncapped cellular mRNA is increased in flavivirus-infected
cells (Fig. 3), the absolute amount of uncapped species
likely remains very small compared with the overall amount
of capped mRNA species due to the only z23 increase
observed in this experiment. It is possible that the in-
hibition of XRN1 by sfRNA formation could feed back
and generally inhibit the 59-to-39 decay pathway. In sup-
port of this idea, P-bodies representing subcellular sites
where factors involved in 59-to-39 mRNA decay can be
concentrated are dispersed in flavivirus infections (Emara
and Brinton 2007). This observation could suggest a gen-
eral disruption of the 59-to-39 decay pathway. As seen in
FIGURE 2. sfRNA formation inhibits the cellular exoribonuclease XRN1. A radiolabeled RNA
containing a 59 monophosphate (Reporter) was incubated for the time indicated in HeLa (A)
or C6/36 (B) cytoplasmic extract under conditions that favor 59-to-39 decay or with purified
recombinant XRN1 (C). The lanes labeled ‘‘Control’’ indicate reactions that were performed in
the absence of any competitor RNA. A 303 molar excess of lightly radiolabeled nonspecific
competitor RNA (‘‘Non-Specific’’ lanes) or a competitor transcript containing the proximal
half of the 39 UTR of Dengue virus type 2 (‘‘DenV 39 UTR’’ lanes) was added to reactions. The
59 end of the competitors contained either a 59 cap or a 59 monophosphate as indicated above
the lanes. After the times indicated, reaction products were analyzed on 5% polyacrylamide
gels containing urea and visualized by phosphorimaging. The numbers under the lanes represent
the means 6 standard deviation of the amount of starting reporter RNA remaining in three
independent experimental replicates.
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Figure 5, knockdown of XRN1 to z32% of normal levels
resulted in a significant increase in the half-lives of the two
endogenous mRNAs sampled. This demonstrates that as
predicted, XRN1 depletion resulted in an increase in the
stability of cellular mRNAs. Therefore, we set out to assess
relative mRNA half-lives in mock- and flavivirus-infected
cells.
Mock- or virus-infected cells were treated with actino-
mycin D for 30 min to shut off cellular transcription, and
RNA samples were isolated at the indicated times post–
drug treatment. Levels of the FOS and TUT1 mRNAs at
each time point were assessed by qRT-PCR and compared
to generate mRNA decay curves and determine transcript
half-lives. Infection with either DenV2 (Fig. 6) or Kunjin
virus (Fig. 7A) resulted in a significant stabilization of
both the FOS and TUT1mRNAs compared with uninfected
cells. Notably, the degree of stabilization as seen in the
decay curves or calculated mRNA half-lives was strongly
associated with the amount of sfRNA present in the in-
fected cells (cf. the graphs to the Northern blots in Figs. 6
and 7A). Similar data were obtained in flavivirus infections
of mosquito cells (data not shown). Importantly, infection
with a mutant Kunjin virus that cannot produce sfRNA
(Fig. 7B) also failed to cause significant stabilization of
cellular mRNAs. This Kunjin virus mutant replicated to
similar levels as the parent wild-type Kunjin virus in these
293T cells (Supplemental Fig. 1A). Collectively, these data
indicate that cellular mRNAs are stabi-
lized in infections with independent fla-
viviruses that are capable of producing
sfRNA.
To demonstrate that sfRNA produc-
tion is sufficient for the stabilization
of mRNAs, we transfected 293T cells
with either a control GFP-expressing
reporter construct or with a GFP re-
porter containing the DenV2 39-UTR
sequence downstream from GFP and
thus producing sfRNA. As seen in Fig-
ure 8A, sfRNA was efficiently detected
only from the reporter construct con-
taining the DenV2 39-UTR sequences.
Interestingly, the sfRNA-generating trans-
fected reporter construct also caused a
significant stabilization of cellular mRNAs
compared with the GFP-only reporter.
Collectively, these data indicate that a
reporter RNA that possesses the DenV2
39 UTR (and generates sfRNA) causes
stabilization of cellular mRNAs in the
absence of a virus infection. This dem-
onstrates that sfRNA generation on its
own is necessary and sufficient to cause
the stabilization of cellular mRNAs.
Cellular gene expression is significantly dysregulated
by an sfRNA-producing flavivirus
Finally, we wished to assess the scale of the global effects on
cellular gene expression mediated by sfRNA production/
XRN1 repression in a flavivirus infection. Interferon a/b
FIGURE 4. XRN1 protein preferentially binds to sfRNA in Kunjin or
Dengue virus infections. 293T cells were infected with Kunjin virus for
2 d or Dengue virus for 4 d. RNA–protein complexes were stabilized
with formaldehyde and immunoprecipitated with XRN1 antibody
(a-XRN1 lanes) or matched amounts of a control IgG (IgG lanes).
Coprecipitating RNAs were detected by RT-PCR (A) or qRT-PCR (B)
using the primers indicated.
FIGURE 3. Uncapped mRNAs accumulate in flavivirus-infected cells due to XRN1 inhibition
by sfRNA formation. 293T cells were either mock-treated or infected with Dengue virus
(DenV) (A), Kunjin virus (KUN) (B), or a Kunjin virus mutant that cannot make sfRNA
(KUN sfRNA-) (B) for the times indicated. Total RNA was isolated and immunoprecipitated
using a cap-specific antibody. The presence of FOS and TUT1 mRNAs was measured in the
input, capped, and uncapped fractions by qRT-PCR. The relative amount of uncapped RNAs
was normalized to 7SL RNA and to the total amount of capped RNA present in the sample and
expressed in the graphs relative to the level of uncapped mRNAs in mock-infected samples.
Error bars represent the standard error of the mean in the indicated samples.
sfRNA inhibits the cellular exonuclease XRN1
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receptor-negative mouse embryo fibroblasts (MEFs) that are
highly sensitive to flavivirus infection were mock-infected,
infected with wild-type Kunjin virus, or infected with an
sfRNA mutant Kunjin virus for 48 h. Both wild-type and
mutant viruses replicated to the same level in these cells
as measured by qRT-PCR for Kunjin RNA (Supplemental
Fig. 1B). Total RNA samples were obtained and relative
expression level of mRNAs was determined by microarray
analysis (Supplemental Fig. 2). The heat map shown in
Figure 9A illustrates two interesting points from this
analysis. First, a set of 416 cellular mRNAs was found to
be significantly (33 or more) overexpressed in a wild-type
Kunjin virus–infected cell compared with mock control.
Interestingly, infection with a Kunjin virus mutant in-
capable of producing sfRNA failed to increase expression
of most (378) of these mRNAs to the levels seen in wild-
type Kunjin virus–infected cells. Analysis of Gene Ontogeny
(GO) terms associated with this up-regulated set of tran-
scripts indicates that mRNAs associated with the innate
immune, inflammation, cell adhesion, stress responses,
and cell proliferation are significantly (p # 0.01) over-
represented. The relative overexpression of four of these
mRNAs in wild-type as compared with sfRNA mutant
Kunjin virus infection was confirmed and generalized in
an independent cell line by qRT-PCR analyses of total
RNA samples obtained from infected 293T cells (Fig. 9B).
Collectively, these data indicate that a significant amount
of up-regulation of cellular gene expression is associated
with sfRNA production during a flavivirus infection. Since
the amount of uncapped mRNA that accumulated during
a Kunjin virus infection likely remains
relatively small compared with the total
amount of capped mRNA (Fig. 3), this in-
crease in mRNA levels noted in the array
analysis may largely represent capped,
functional mRNA. The shutdown of
XRN1 by the generation of sfRNA could
be responsible for the up-regulation of
many of these transcripts.
Curiously, another set of mRNAs was
significantly down-regulated in wild-
type Kunjin infection whose expression
was only mildly reduced in infections
with an sfRNA mutant Kunjin virus (Fig.
9A, bottom portion of heat map). Anal-
ysis of GO terms associated with this
down-regulated set of transcripts indi-
cates that mRNAs associated with the
cellular response to virus infections,
stress, and anti-apoptosis are significantly
(p# 0.01) over-represented. The down-
regulation of these transcripts associ-
ated with sfRNA-producing Kunjin virus
infections may be a direct or indirect
effect of sfRNA formation. In summary,
the production of sfRNA during a Kunjin virus infection
is associated with major global changes in cellular gene
expression.
DISCUSSION
This study describes the characterization of a novel virus-
derived RNA inhibitor of the major cellular RNA decay
FIGURE 5. Cellular mRNAs are stabilized upon XRN1 depletion. (A) XRN1 was depleted in
293T cells using specific XRN1 KD, or cells were treated with control (LKO.1) shRNA vectors.
The bar graph illustrates the efficiency of XRN1 knockdown as measured by qRT-PCR. (B)
TUT1 and FOS mRNA half-lives were determined after actinomycin D treatment by qRT-PCR
in the respective graphs. Average half-lives are reported 6standard deviations from two
independent experiments. (*) P-values <0.05.
FIGURE 6. Cellular mRNAs are stabilized by sfRNA formation in
Dengue virus infection. (A) 293T cells were infected with Dengue
virus type 2 for the times indicated (days post-infection, d.p.i.)
and the levels of sfRNA were determined by Northern blotting. (B)
The half-lives of the TUT1 and FOS mRNAs were determined after
actinomycin D treatment by qRT-PCR. Average mRNA half-lives
from two independent infections are reported 6standard deviation in
parentheses. (*) P-values <0.05.
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factor XRN1. While poly(G) tracts and related structural
elements have been used in the past to stall the exoribo-
nuclease in yeast and trypanosomes (Muhlrad et al. 1994;
Li et al. 2006), these types of structures
have not consistently worked in mam-
malian cells. The observation that the
pseudoknot structures in sfRNA can-
not only stall XRN1 from a variety of
sources but also inhibit the enzymatic
activity was, therefore, rather unexpected.
Pseudoknots and related structures have
been shown in the past to hinder the
action of other enzymatic complexes
that move directionally along RNA. They
can serve as roadblocks for ribosomes
(Tholstrup et al. 2012) and influence
frameshifting rates (Namy et al. 2006).
Based on previous work (Pijlman
et al. 2008; Funk et al. 2010; Silva et al.
2010) and our observations for Dengue
and West Nile viruses reported here, the
ability to generate sfRNA and repress
XRN1 is likely to be conserved through-
out the arthropod-borne flaviviruses.
Since the formation of sfRNA inacti-
vates XRN1 in both mosquito and hu-
man cell extracts (Figs. 1, 2), other
non-arthropod-borne members of the
Flaviviridae such as hepatitis C virus
and Bovine Viral Diarrhea virus may interface with the
cellular RNA decay machinery by a related mechanism. It is
clear that naturally uncapped viral mRNAs from HCV have
FIGURE 7. Cellular mRNAs are stabilized in an sfRNA-dependent fashion in Kunjin virus infection. Human 293T cells were infected with either
wild-type Kunjin virus (A) or an sfRNA-deficient mutant Kunjin virus that fails to produce sfRNA due to structural mutations in the 39 UTR (B).
Northern blot analysis showed the presence or absence of sfRNA accumulation in infected cells (panels at left). Transcriptional shutoff by
actinomycin D treatment was done at 48 hpi, and the half-lives of FOS and TUT1 mRNAs were determined by qRT-PCR. Half-lives were
calculated from two independent experiments and are expressed as 6standard deviations. (*) P-values <0.05.
FIGURE 8. The formation of sfRNA in the absence of flaviviral infection induces cellular
mRNA stabilization. GFP expression plasmids either expressing GFP only (‘‘GFP Only’’ lane)
or a GFP mRNA with the sfRNA-producing Dengue virus type 2 39 UTR in its 39 UTR
(‘‘DenV 39 UTR’’ lane) were transfected into 293T cells. (A) Northern blot probed to detect the
Dengue virus 39 UTR present in sfRNA-like fragments. (B) Transfected cells were treated with
actinomycin D, and RNA samples were taken at the indicated times post-transcriptional
shutoff. The levels of the indicated TUT1 or FOS mRNAs were assessed by qRT-PCR, and the
means of three experiments are presented graphically. The half-lives shown in the graph insets
are means of at least two independent experiments 6 standard deviations. (*) P-values <0.05.
sfRNA inhibits the cellular exonuclease XRN1
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defined mechanisms to protect viral mRNAs from 59 exo-
nucleases like XRN1 (Shimakami et al. 2012). Human
enteroviruses/rhinoviruses also have developed ways to
protect their transcripts from XRN1 (Murray et al. 2001;
Kempf and Barton 2008a,b). Other positive-strand RNA
viruses have well-described structural elements that might
be able to stall and/or inhibit XRN1. These include the
large stem–loop structures present in the ambisense RNA
segments of arenaviruses (Pinschewer et al. 2005) and
pseudoknot/double hairpin structures of coronaviruses
(Stammler et al. 2011). Several positive-sense plant viruses
also generate some apparent subgenomic stable decay prod-
ucts that may arise by a mechanism similar to the flavivirus
sfRNA (Iwakawa et al. 2008; Peltier et al. 2012). We are
currently assessing if these viruses may interact with XRN1
through mechanisms related to those we describe here for
Dengue and West Nile viruses.
The repression of XRN1 by flaviviruses could have
several important consequences during an infection. While
the level of uncapped mRNAs is increased (Fig. 3), the
relative amount of uncapped mRNAs is still rather small
compared with the large amount of capped versions of
individual mRNAs in infected cells. Therefore, the increase
in the relative level of uncapped mRNA in infected cells
is almost certainly not sufficient to account for the increase
in cellular mRNA half-lives that we detect in infected cells
(Figs. 6–8). Uncapped mRNA levels, however, could serve
to send a signal to the cell, perhaps through novel pattern
recognition receptors. Shutting down the major 59-to-39
decay pathway in cells is very likely to have significant
ramifications for the cell. Factors of this pathway demon-
strate a great deal of cross-communication (Garneau et al.
2007; Kulkarni et al. 2010). Thus the repression of XRN1
activity is likely to feed back and disrupt other components
of the pathway. P-bodies, for example, which are known to
contain concentrations of interacting 59-to-39 decay path-
way components (Beckham and Parker 2008), are disrupted
in West Nile and Dengue infections by an as-yet-unknown
mechanism (Emara and Brinton 2007). Perhaps this is re-
lated to sfRNA formation and is a consequence of the
FIGURE 9. Numerous cellular mRNAs are up-regulated in Kunjin virus-infected cells due to sfRNA formation. (A) Interferon a/b receptor–
deficient mouse embryo fibroblasts were mock-infected or infected with either wild-type (wt) or sfRNA Kunjin virus for 48 h. Total RNA
samples were isolated at 48 hpi, and cellular gene expression levels were assessed globally by microarray analysis. Robust multiarray analysis
(RMA) values were calculated, and hierarchical clustering was performed for genes having threefold or more difference in RMA values after
transforming the values to have mean 0 and standard deviation 1. The color key represents the transformed values. (B) Levels of the four indicated
mRNAs were assessed by qRT-PCR of total RNA isolated from independent infections of 293T cells using wild type or an sfRNA-deficient Kunjin
virus at 48 hpi. The results shown are the mean of three independent infections, and error bars represent the standard error of the means.
Significance was determined using a one-tailed t-test.
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direct feedback of XRN1 repression that disrupts the en-
tire pathway. Disrupting 59–39 mRNA decay should result
in a significant interference of cellular RNA regulation—as
evidenced by the changes in mRNA half-lives (Figs. 6–8)
and inferred from the dramatic changes in mRNA expres-
sion (Fig. 9) observed in this study.
Alterations on cellular mRNA stability by flavivirus
sfRNA are likely to have a significant mechanistic role in
viral-induced pathogenesis. Based on models of the kinetics
of mRNA accumulation (Elkon et al. 2010), the alterations
in mRNA half-lives that we observe during flavivirus in-
fections are likely to have a much greater influence on the
expression of naturally short-lived mRNAs as compared
with longer-lived transcripts. Interestingly, many cytokines
and factors involved in aspects of innate immunity are of-
ten encoded by short-lived transcripts (Schott and Stoecklin
2010). Thus flaviviruses may use this strategy to disturb
the normal regulation of these factors and escape cellular
surveillance mechanisms that would normally limit their
replication and perhaps induce immunopathogenesis. As
a timely example of this, West Nile virus sfRNA has been
recently shown to interfere with an interferon response
(Schuessler et al. 2012). In addition, cell cycle genes and
several major transcriptional regulators in mammalian cells
are also encoded by short-lived mRNAs. Thus, disrupting
these families of mRNAs may contribute to cytopathology
during viral infections. Previous work has indeed demon-
strated that West Nile virus variants that are incapable
of generating sfRNA replicate less efficiently in some cell
types and cause a significantly reduced cytopathology com-
pared with the wild-type virus (Pijlman et al. 2008). We
are currently assessing global mRNA half-life changes in
flavivirus-infected cells to obtain a clear picture of the effect
of sfRNA production on a variety of cellular pathways and
RNA regulons.
In summary, flavivirus sfRNA demonstrates a novel way
that an RNA virus interfaces with the cellular mRNA decay
machinery. This may assist in the stabilization of viral
transcripts as well as cause a disruption of the regulation of
host cell gene expression. The data described here, along
with other recently reported examples of viral RNA inter-
actions with the cellular RNA decay machinery (Sokoloski
et al. 2010; Dougherty et al. 2011; Palusa et al. 2012), demon-
strate interesting aspects of viral RNA–host interactions that
have potentially broad biological implications. These findings
also present a potential target for the development of broad-
spectrum antivirals as well as discovery tools for novel insights
into mechanisms and regulation of cellular mRNA stability.
MATERIALS AND METHODS
Cell lines and virus propagation
C6/36, LLC-MK2, and BHK-21 cells were grown in MEM (Media-
tech, Inc.) with 10% fetal bovine serum (FBS). 293T and Vero
cells were maintained in DMEM (Mediatech, Inc.) with 10% FBS.
HeLa cells were grown in MEM supplemented with 10% horse
serum. Mouse embryonic fibroblasts were generated at Osaka
University as previously described. Mouse protocols were ap-
proved by the Osaka University Animal Care and Use Commit-
tee (H19-16-0 and H20-03-0). All experiments were in accor-
dance with the specifications of the Association for Assessment
and Accreditation of Laboratory Animal Care.
Dengue virus type 2 (Jamaica 1409) was propagated on C6/36
cells and titers determined by plaque titration on LLC-MK2 cells.
Kunjin viruses (FLSDX and FL-IRAdCS3) were recovered from
corresponding infectious cDNA clones (Pijlman et al. 2008),
propagated on Vero cells and titers determined using plaque
titration on BHK-21 cells. 293T cells were infected with Dengue
virus or Kunjin virus at a multiplicity of infection of 1 PFU/cell.
Virus was allowed to adsorb for 2 h, cells were rinsed twice with
maintenance medium, and experiments were performed at the
indicated times after adsorption.
Plasmids and transfections
The Dengue virus type 2 39 untranslated region was amplified
from total infected cellular RNA using RT-PCR with the fol-
lowing primers: 59-GCGGCCGCAAGGCAAAACTAACATGAAC,
59-GCGGCCGCAGAACCTGTTGATTCAACAG and cloned into
the NotI site in the 39 untranslated region of eGFP in peGFP-N1
to create the DenV 39-UTR-containing reporter plasmid. Purified
plasmid DNA treated with MiraClean endotoxin reagent was
transfected into 293T cells using Lipofectamine 2000 (Invitrogen).
Cell-free XRN1 RNA decay assays
The reporter RNA for XRN1 assays was derived from pGem4
digested with Ear I. To prepare the Reporter-DenV 39-UTR RNA,
the stem–loop 1 region of the 39 UTR of Dengue virus type 2
that contains the first pseudoknot-type structure previously im-
plicated in sfRNA formation (Funk et al. 2010; Silva et al. 2010)
(59-AAGAAGUCAGGCCAUCACAAAUGCCACAGCUUGAGUA
AACUGUGCAGCCUGUAGCUCCACC) was PCR-amplified and
cloned into pGem4 at the XbaI and HindIII sites. Plasmid DNA
was linearized with EarI. The nonspecific competitor RNA was
derived from pGem4 templates digested with SmlI. To prepare
the DenV 39-UTR competitor RNA, the proximal half of the
39 UTR of Dengue virus type 2 that contains both of the
pseudoknot-type structures previously implicated in sfRNA for-






CGCAUGGCGUAG) was PCR-amplified and cloned into pGem4
at the XbaI and HindIII sites. Plasmid DNA was linearized with
EarI. RNAs were made by in vitro transcription using SP6 poly-
merase in the presence of a 103 molar excess of cap analog or
59 GMP to GTP in the reaction in order to obtain transcripts
with a 59 cap or 59 monophosphate, respectively. Approximately
30 fm of radioactive RNAs was incubated in HeLa or C6/36
cytoplasmic S100 extracts prepared as described previously (Ford
et al. 1999; Sokoloski et al. 2008) under conditions that strongly
sfRNA inhibits the cellular exonuclease XRN1
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favor 59-to-39 exonucleolytic decay (Mukherjee et al. 2002) or
with recombinant yeast XRN1 protein (New England Biolabs)
for the times indicated. Reaction products were analyzed on 5%
polyacrylamide gels containing 7 M urea and visualized by
phosphorimaging.
XRN1 knockdown was achieved by lentivirus-mediated trans-
duction of a Mission shRNA vector (Sigma-Aldrich) specific to
XRN1 (TRCN0000049677) or the empty LKO.1 vector lacking a
specific shRNA sequence. Two days after lentivirus transduction,
293T cell pools were selected for shRNA expression with puro-
mycin (5 mg/mL). XRN1 expression was determined by qRT-PCR
(forward primer: 59-GCGGCACCTGCCATCTTCTGA; and re-
verse primer: 59-GAACTGTCAGCTTGCTGTGCTCAA).
mRNA half-life analysis
Maintenance medium was replaced with fresh medium contain-
ing the transcriptional inhibitor actinomycin D (5 mg/mL) and
RNA collections begun after 30 min of drug treatment to ensure
complete shutoff of cellular transcription. Total RNA was isolated
using TRIzol (Invitrogen) and treated with DNase I (Fermentas).
Reverse transcription was done using 1 mg of total RNA with
Improm-II Reverse Transcriptase (Promega) and random hexamer
primers. The abundance of GAPDH, FOS, and TUT1 mRNA was
determined by quantitative real-time PCR using the CFX96 real-
time PCR detection system and Bio-Rad SYBR-Green supermix.
The primers used were as follows: GAPDH forward: 59-TCTT
TTGCGTCGCCAGCCGA; GAPDH reverse: 59-ACCAGGCGC
CCAATACGACC; TUT1 forward: 59-AGGCAGCCCAAGAATGG
TC; TUT1 reverse: 59-GCCACCACTCAGTCCTTTCA; FOS for-
ward: 59-GTGGGAATGAAGTTGGCACT; FOS reverse: 59-CTAC
CACTCACCCGCAGACT. The DDCt method was used to analyze
data using GAPDH as a reference gene. The data shown represent
the mean values from at least two independent experiments and
error bars and 6calculations represent the standard deviation of
each measurement. P-values were determined by a Student’s t-test.
Northern blotting
One microgram of total RNA was run on a 5% denaturing poly-
acrylamide gel and transferred to a nylon membrane (Amersham
Hybond-XL). Internally radiolabeled probes containing the anti-
sense 39 untranslated regions of Dengue virus or Kunjin virus
were hybridized to the membrane, and RNAs were visualized by
phosphorimaging.
Immunoprecipitation of capped mRNAs
Total RNA from cells infected with Dengue virus or Kunjin virus
at the indicated times post-infection was fractionated into capped
and uncapped portions using a mouse monoclonal antibody
to m3G-cap/m7G-cap (Synaptic Systems) following the manufac-
turer’s protocol. RNA was purified from 10% of the input sample,
the supernatant (unbound) fraction, and the immunoprecipitated
fraction and reverse-transcribed using Improm II reverse tran-
scriptase (Promega). The abundance of 7SL, FOS, and TUT1
mRNA was determined by qRT-PCR using the Bio-Rad CFX96
real-time PCR detection system and Bio-Rad SYBR-Green super-
mix using the TUT1 and FOS primers described above and the
following: 7SL forward: 59-GGAGTTCTGGGCTGTAGTGC; 7SL
reverse: 59-ATCAGCACGGGAGTTTTGAC. The relative abundance
of FOS and TUT1 mRNA in the uncapped fractions was de-
termined relative to the immunoprecipitated, capped fractions
using the DDCt method with 7SL as the reference gene. Total
relative amount of uncapped FOS and TUT1 mRNAs in each
sample was determined by comparing with the abundance in the
10% input sample.
Coimmunoprecipitation of XRN1 and viral RNAs
293T cells infected with Dengue virus (at 4 d post-infection) or
Kunjin virus (at 2 d post-infection) were washed with PBS,
resuspended in 1% formaldehyde, and rocked 15 min at room
temperature. The reaction was stopped after 15 min with 0.25 M
glycine. Cells were rinsed with PBS and resuspended in cold
RIPA buffer (50 mM Tris at pH 7.5, 1% NP-40 [v/v], 0.5%
sodium deoxycholate, 0.05% SDS [w/v], 1 mM EDTA, 150 mM
sodium chloride) plus 1 mL of RNase inhibitor (Fermentas). Lysates
were sonicated and insoluble particles removed by centrifugation.
Lysates plus 2 mL of rabbit monoclonal XRN1 antibody (the kind
gift of Dr. J. Lykke-Andersen) or 2 mL of normal rabbit IgG
and 1 mL of RNase inhibitor (Fermentas) were rotated for 1 h at
4°C. Pansorbin Staph A-positive cells were added to the lysates
and incubated for 15 min at 4°C with rotation. Pellets were
resuspended in RIPA containing 1 M urea and vortexed vigor-
ously, and washed five times with RIPA with 1 M urea. All sam-
ples were heated to 70°C with shaking for 45 min to reverse
formaldehyde cross-links. Supernatants were collected following
centrifugation to remove insoluble particles and RNA extracted
using TRIzol (Invitrogen) following the manufacturer’s instruc-
tions. RNA was treated with DNase I (Fermentas) and reverse-
transcribed with random hexamer primers. Viral 39 UTR, NS3, or
NS5 was amplified using Taq polymerase (GoTaq Flexi; Promega)
with the following primers: Kunjin 39 UTR forward: 59-GGAG
ACCCCGTGCCGCAAAA and reverse: 59-CACTGTGCCGTGTG
GCTGGT; Kunjin NS3 forward: 59-TGGACGGGGAATACCGAC
TTAGAGG and reverse: 59-ACCCCAGCTGCTGCCACCTT; Dengue
39 UTR forward: 59-AGGCCATCACAAATGCCACAGC and re-
verse: 59-ACGCCATGCGTACAGCTTCCA; Dengue NS5 forward:
59-GTGCGTGTGCAAAGACCAACACC and reverse: 59-AAGGC
CATAGGTGCCGACTTGC. PCR products were run on a 2%
agarose gel and stained with ethidium bromide, and band in-
tensities were quantified using Quantity One software.
Microarray analysis
IFNAR-deficient MEF cells were infected with wild-type Kunjin
virus or the sfRNA-deficient IRAdCS3 mutant virus at an MOI
of 1 PFU/cell. At 48 h post-infection, total RNA was isolated us-
ing TRIzol (Invitrogen), further purified with the RNeasy Mini kit
(QIAGEN), and then subjected to cDNA library preparation with
the WT-Ovation RNA Amplification System and Encore Biotin
Module (Nugen) according to the manufacturers’ instructions.
The resulting cDNA was hybridized to Mouse 430 2.0 Arrays
(Affymetrix). The arrays were washed, stained, and scanned ac-
cording to the manufacturer’s recommendations. Robust multi-
array analysis (RMA) values were calculated and hierarchical
clustering was performed for genes having threefold or more
differences in RMA values after transforming the values to have
mean 0 and standard deviation 1. Genes were placed into six
clusters according to Akaike’s information criterion. All calculations
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were done using R and Bioconductor. Relative increases in ex-
pression were confirmed for the four indicated cellular mRNAs by
qRT-PCR analysis of samples obtained from three independent
infections using an MOI of 5 PFU/cell. The following primers
were used in the analysis: CXCL11: 59-CATGAGTGTGAAGGG
CATGGCT and 59-CCAGGGCCTATGCAAAGACAGCG; CCL2:
59-TGAAGCTCGCACTCTCGCCT and 59-TGAGCGAGCCCTT
GGGGAATGA; OASL: 59-TCCTTCAGCGAGCTGCAGAGAAAT
and 59-CCGGATCCAGGATGATGGGCCT; and IL6: 59-TCGAG
CCCACCGGGAACGAA and 59-GCAACTGGACCGAAGGCGCT.
SUPPLEMENTAL MATERIAL
Supplemental material is available for this article.
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